Spectrophotometric determination of fenoterol hydrobromide in pure form and dosage forms.
A sensitive and rapid spectrophotometric procedure has been investigated for the determination of fenoterol either per se or in pharmaceutical preparations. The proposed procedure is based on the reaction between the drug and 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) at pH 7.2, using borate buffer, to produce a yellow adduct. The latter has maximum absorbance at 400 nm and obeys Beer's law within the concentration range 5-30 microg/ml. Regression analysis of the calibration data showed a good correlation coefficient (r=0.9996) with minimum detection limit of 0.24 microg/ml (6.2 x 10(-8) M). The proposed procedure has been successfully applied to the determination of this drug in its tablets and in syrup, the mean percent recoveries were 97.45+/-0.59 and 98.7+/-0.64%, respectively. The results obtained are in good agreement with those given using a reference method. The pharmaceutical additives other than active ingredient did not interfere. A proposal of the reaction pathway has been postulated.
D009327:4-Chloro-7-nitrobenzofurazan / Q000737:chemistry; D001993:Bronchodilator Agents / Q000032:analysis*; D002021:Buffers; D004304:Dosage Forms; D005280:Fenoterol / Q000032:analysis* / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents / Q000737:chemistry; D015203:Reproducibility of Results; D013053:Spectrophotometry / Q000379:methods; D013607:Tablets / Q000032:analysis
D001993:Bronchodilator Agents; D002021:Buffers; D004304:Dosage Forms; D007202:Indicators and Reagents; D013607:Tablets; D005280:Fenoterol; D009327:4-Chloro-7-nitrobenzofurazan